{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:36:27Z","timestamp":1786653387903,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Views"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1995-705x.152997","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T02:21:17Z","timestamp":1426040477000},"page":"21","source":"Crossref","is-referenced-by-count":4,"title":["Rituximab Induced Left Bundle Branch Block"],"prefix":"10.4103","volume":"16","author":[{"given":"BlairP","family":"Grubb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujeeb","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Moza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1995-705X.152997-1","first-page":"235","volume-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1995-705X.152997-2","doi-asserted-by":"crossref","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 Jul 15;363:221-32.","DOI":"10.1056\/NEJMoa0909905"},{"key":"key-10.4103\/1995-705X.152997-3","first-page":"401","volume-title":"B-cell inhibitors as therapy for rheumatoid arthritis: An update","author":"Kwan-Morley","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"key-10.4103\/1995-705X.152997-4","first-page":"359","volume-title":"Immunotherapy for thrombotic thrombocytopenic purpura","author":"Cataland","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"key-10.4103\/1995-705X.152997-5","unstructured":"Rituxan package insert. San Diego, CA: IDEC Pharmaceuticals; 2001 Apr."},{"key":"key-10.4103\/1995-705X.152997-6","doi-asserted-by":"crossref","unstructured":"Monsuez JJ, Charniot JC, Vignat N, Artigou JY. Cardiac side-effects of cancer chemotherapy. Int J Cardiol 2010 Sep 24; 144:3-15. Epub 2010 Apr 18.","DOI":"10.1016\/j.ijcard.2010.03.003"},{"key":"key-10.4103\/1995-705X.152997-7","first-page":"1927","volume-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study.Blood","author":"Coiffier","year":"1998","journal-title":""},{"key":"key-10.4103\/1995-705X.152997-8","first-page":"317","volume-title":"European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma","author":"Foran","year":"2000","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/1995-705X.152997-9","first-page":"317","volume-title":"Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma","author":"Arai","year":"2005","journal-title":"Am J Hematol"},{"key":"key-10.4103\/1995-705X.152997-10","first-page":"298","volume-title":"Complete atrioventricular block induced by rituximab in monotherapy in an aged patient with non-Hodgkin\u2032s diffuse large B-cell lymphoma","author":"Cervera","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"key-10.4103\/1995-705X.152997-11","first-page":"218","volume-title":"Rituximab-induced polymorphic ventricular tachycardia","author":"Poterucha","year":"2010","journal-title":"Tex Heart Inst J"},{"key":"key-10.4103\/1995-705X.152997-12","first-page":"7935","volume-title":"A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function","author":"Siano","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/1995-705X.152997-13","doi-asserted-by":"crossref","unstructured":"Kanamori H, Tsutsumi Y, Mori A, Kawamura T, Obara S, Shimoyama N, et al. Delayed reduction in left ventricular function following treatment of non-Hodgkin\u2032s lymphoma with chemotherapy and rituximab, unrelated to acute infusion reaction. Cardiology 2006;105:184-7. Epub 2006 Feb 14.","DOI":"10.1159\/000091416"}],"container-title":["Heart Views"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:23Z","timestamp":1786649783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1995-705X.152997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["152997"],"URL":"https:\/\/doi.org\/10.4103\/1995-705x.152997","relation":{},"ISSN":["1995-705X"],"issn-type":[{"value":"1995-705X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}